174 related articles for article (PubMed ID: 29462157)
1. A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy.
Hassan F; Lossie SL; Kasik EP; Channon AM; Ni S; Kennedy MA
PLoS One; 2018; 13(2):e0192882. PubMed ID: 29462157
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-Mediated Delivery of Decoy Hyper Binding Sites Targeting Oncogenic HMGA1 Reduces Pancreatic and Liver Cancer Cell Viability.
Hassan F; Ni S; Arnett TC; McKell MC; Kennedy MA
Mol Ther Oncolytics; 2018 Mar; 8():52-61. PubMed ID: 29511732
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
4. Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.
Grant MA; Baron RM; Macias AA; Layne MD; Perrella MA; Rigby AC
Biochem J; 2009 Feb; 418(1):103-12. PubMed ID: 18937643
[TBL] [Abstract][Full Text] [Related]
5. Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.
Akhter MZ; Luthra K; Rajeswari MR
J Biomol Struct Dyn; 2016; 34(4):877-91. PubMed ID: 26084422
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.
Liau SS; Ashley SW; Whang EE
J Gastrointest Surg; 2006 Nov; 10(9):1254-62; discussion 1263. PubMed ID: 17114012
[TBL] [Abstract][Full Text] [Related]
8. Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells.
Cao YD; Huang PL; Sun XC; Ma J; Jin ZL; Cheng HY; Xu RZ; Li F; Qin SK; Deng YX; Ge XL
Chin Med J (Engl); 2011 Apr; 124(7):1061-8. PubMed ID: 21542969
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Liau SS; Jazag A; Ito K; Whang EE
Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
[TBL] [Abstract][Full Text] [Related]
10. HMGA1-pseudogene overexpression contributes to cancer progression.
Esposito F; De Martino M; Forzati F; Fusco A
Cell Cycle; 2014; 13(23):3636-9. PubMed ID: 25483074
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
12. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.
Baldassarre G; Belletti B; Battista S; Nicoloso MS; Pentimalli F; Fedele M; Croce CM; Fusco A
Oncogene; 2005 Oct; 24(45):6809-19. PubMed ID: 16007157
[TBL] [Abstract][Full Text] [Related]
13. Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5.
Coughlan L; Vallath S; Gros A; Giménez-Alejandre M; Van Rooijen N; Thomas GJ; Baker AH; Cascalló M; Alemany R; Hart IR
Hum Gene Ther; 2012 Sep; 23(9):960-79. PubMed ID: 22708837
[TBL] [Abstract][Full Text] [Related]
14. RNA-Mediated Regulation of HMGA1 Function.
Benecke AG; Eilebrecht S
Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
16. HMGA and Cancer: A Review on Patent Literatures.
De Martino M; Fusco A; Esposito F
Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling.
Chiefari E; Arcidiacono B; Palmieri C; Corigliano DM; Morittu VM; Britti D; Armoni M; Foti DP; Brunetti A
Sci Rep; 2018 Jun; 8(1):8540. PubMed ID: 29867121
[TBL] [Abstract][Full Text] [Related]
18. Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.
Maasch C; Vater A; Buchner K; Purschke WG; Eulberg D; Vonhoff S; Klussmann S
J Biol Chem; 2010 Dec; 285(51):40012-8. PubMed ID: 20961861
[TBL] [Abstract][Full Text] [Related]
19. The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells.
Senigagliesi B; Penzo C; Severino LU; Maraspini R; Petrosino S; Morales-Navarrete H; Pobega E; Ambrosetti E; Parisse P; Pegoraro S; Manfioletti G; Casalis L; Sgarra R
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167352
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver.
Zhang HG; Zhou T; Yang P; Edwards CK; Curiel DT; Mountz JD
Hum Gene Ther; 1998 Sep; 9(13):1875-84. PubMed ID: 9741426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
